Adj. net profit +3%/+5% and adj. PBLL -1%/+2% vs. ABG/Infront cons. Miss PBLL from weaker NII & fees, while better PTP from lower LLP. Cons.est. -1-3% for 24e-25e (NII); stock same, but share BB mute
We just expect a neutral risk/reward into the numbers for DNB, as we are just ahead / aligned with consensus' profit before loan losses & pre-tax profit.
Cash yields and cost management increasingly important. We stay positive with four BUY ratings out of six. Positive risk/reward in Nordea and negative in Danske Bank.
The total number of bankruptcies was up 32% y-o-y and down 12% m-o-m in March 2024. Corporate bankruptcies were up 36% y-o-y and down 13% m-o-m in March 2024.
Total lending decreased by 0.2% y-o-y (corporate lending -1.6% and retail lending 0.6%) and by -0.1% m-o-m. Last month, total lending was down by 0.1% y-o-y (corporate lending -1.3% and retail lending 0.6%)
Total lending in February was up 3.3% y-o-y (corporate +4.8%; retail +2.4%) and was flat (0.0%) m-o-m. Last month, total lending was up 2.7% y-o-y (corporate +4.3%; retail +1.8%).
Total lending decreased by 0.4% y-o-y (corporate lending -1.4% and retail lending 0.2%) and by 0.1% m-o-m. Last month, total lending was up by 0.3% y-o-y (corporate lending 0.3% and retail lending 0.4%)
Total lending in January was up 2.7% y-o-y (corporate +4.3%; retail +1.8%) and was down 0.3% m-o-m. Last month, total lending was up 3.8% y-o-y (corporate +4.9%; retail +3.1%).
Adj . PTP missed our expectations on higher costs , loan losses. Higher NII, trading & associates muted by costs. Dividend yield of ~9% compares well vs . peers: HOLD.
Softer underlying PBLL saved by lower loan losses and capital gains. Adj. EPS up 6% and 3% amid higher NII & associates; costs mute. Norm. RONAV of 13% supports 1.4x P/NAV gives more upside: BUY.
Q4: Adj. PTP +13% vs. ABGSCe and +18% vs. cons. on NII & cost. Adj. EPS in '24e-'25e up 3% on wider higher lending. Reiteriate BUY given its strong ROE, yield and superior C/I-ratios.